schizandrin b has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Du, C; Jiang, Y; Liu, C; Tong, Q; Wang, J; Zhang, Q | 2 |
2 other study(ies) available for schizandrin b and Glioma
| Article | Year |
|---|---|
Schisandrin B suppresses glioma cell metastasis mediated by inhibition of mTOR/MMP-9 signal pathway.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cyclooctanes; Dose-Response Relationship, Drug; Glioma; Humans; Lignans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Polycyclic Compounds; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Schisandrin B inhibits the proliferation and invasion of glioma cells by regulating the HOTAIR-micoRNA-125a-mTOR pathway.
Topics: Analysis of Variance; Anti-Inflammatory Agents; Cell Count; Cell Line, Tumor; Cell Proliferation; Cyclooctanes; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioma; Humans; Lignans; MicroRNAs; Neoplasm Invasiveness; Polycyclic Compounds; RNA, Long Noncoding; Signal Transduction; TOR Serine-Threonine Kinases; Transfection | 2017 |